Shorter courses of radiation effective for treatment of slow-growing skin cancers
Can't see this email? View it online
   
  February 5, 2018  
  Skin Cancer  
  The latest skin cancer news from News Medical  
 Shorter courses of radiation effective for treatment of slow-growing skin cancersShorter courses of radiation effective for treatment of slow-growing skin cancers
 
A recent Penn State College of Medicine physician's study review suggests that shorter courses of radiation are preferable to longer ones for older patients receiving treatment for slow-growing skin cancers.
 
   Using structural analysis to improve anti-TNF treatmentsUsing structural analysis to improve anti-TNF treatments
 
The lowering of TNFα levels using these anti-TNFα agents significantly decreases chronic pathologic inflammatory responses in inflammatory diseases.
 
 Cancer risk can be reduced with unique regulations for water treatment
 
Cancer risk can be reduced with unique regulations for water treatmentDr. Megan Rockafellow-Baldoni, Rutgers School of Public Health alum and Center for Public Health Workforce Development program coordinator, has found a reduction in the risk of cancer due to arsenic exposure in Hopewell Township (Mercer County), New Jersey with use of arsenic treatment systems. Arsenic exists in varying levels in all parts of New Jersey; chronic exposure can increase rates of bladder, lung, liver, kidney, and skin cancers.
 
 
 Researchers use innovative method to screen kinases for cancer drug's effectiveness
 
Researchers use innovative method to screen kinases for cancer drug's effectivenessIn recent years, a powerful suite of drugs known as kinase inhibitors have been developed to treat cancer and other diseases. Primary targets of such drugs include a family of receptor tyrosine kinases (RTKs) which protrude from cell surfaces like antennae and can activate cancer-related pathways in virtually all types of cancer when signaling molecules bind with them.
 
 
 Study lays groundwork for using PD-1 inhibitors against aggressive form of pediatric brain cancer
 
Study lays groundwork for using PD-1 inhibitors against aggressive form of pediatric brain cancerOne type of immunotherapy removes a genetic blindfold that cancer uses to hide from the immune system. These "PD-1 inhibitors", including drugs like pembrolizumab, nivolumab and atezolizumab, have proven useful and have even in some cases revolutionized the treatment of common adult cancers ranging from melanoma, to lung cancer, to kidney cancer and more.
 
 
 NUS scientists develop new way to wirelessly deliver light for cancer treatment
 
NUS scientists develop new way to wirelessly deliver light for cancer treatmentA team of scientists from the National University of Singapore has developed a way to wirelessly deliver light into deep regions of the body to activate light-sensitive drugs for photodynamic therapy.